- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00218504
Responses to Marijuana-Related Cues Versus Neutral Cues in Adults Taking Tetrahydrocannabinol (THC) - 2
Cue Reactivity Model for Assessing Pharmacologic Intervention in Treatment of Cannabis Use Disorders (Study 2)
Study Overview
Detailed Description
Marijuana is the most commonly used illegal drug in the United States; more than 2 million Americans either abuse or are dependent on the drug. Therefore, there is a clear need for treatment options. Past research on marijuana treatments has focused on alleviating withdrawal symptoms. Minimal focus has been placed on how altering craving effects may play a role in treating marijuana addiction. Treatment with THC, a component of marijuana that causes the "high" sensation, may reduce marijuana cravings. This study will evaluate the subjective and physiological responses to marijuana-related cues versus non marijuana-related cues in marijuana users who have been pre-treated with THC.
Participants will attend three 6-hour sessions, each separated by at least 7 days. Prior to each testing session, participants will spend the night at the Psychiatric and Addiction Research Center at Detroit Receiving Hospital in order to ensure no alcohol or drug use during the 12 hours preceding the session. Participants will be randomly assigned to receive an oral dose of 10 mg of THC, 20 mg of THC, or placebo. They will then undergo a cue exposure test during which they will be shown a nature video and will be asked to handle and smell various items; these will act as neutral, non marijuana-related cues. Next, the participants will watch a video of individuals smoking marijuana and will be asked to handle and smell marijuana-related items; these will act as the marijuana-related cues. Heart rate and skin temperature will be monitored continuously throughout each session with the use of electrodes and a skin thermometer. Prior to and after the cue exposure sessions blood pressure will be measured and questionnaires will be administered to assess drug cravings as well as related mood states. Prior to leaving the clinical center, the participants' vital signs will be evaluated to ensure that any cue-related physiological changes have returned to normal. Following the end of the study session, participants will have the option of talking to a clinician experienced in dealing with drug cravings.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
Michigan
-
Detroit, Michigan, United States, 48207
- Wayne State University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Meets DSM-IV diagnosis criteria for marijuana dependence
- Able to read and write in English
- Positive urine test for marijuana
- If female, must be willing to use contraception throughout the study
Exclusion Criteria:
- Meets DSM-IV diagnosis criteria for a psychiatric illness
- History of a psychotic disorder
- Seeking treatment for marijuana dependence
- Neurologic disease, including structural brain abnormalities (e.g., neoplasms), stroke, seizures, infectious disease, head trauma resulting in unconsciousness, or evidence of neurologic illness resulting from HIV/AIDS
- Cardiovascular disease, including edema, chest pain or palpitations after exertion or drug use, myocardial infarction (heart attack), systolic blood pressure greater than 160 mm Hg or less than 95 mm Hg, or diastolic blood pressure greater than 95 mm Hg
- Pulmonary disease, including apnea, cor pulmonale, tuberculosis, dyspnea, orthopnea, or tachypnea
- Systemic disease, including endocrinopathies, kidney or liver failure, hypothyroidism, adrenocortical insufficiency, or autoimmune disease involving the central nervous system
- Currently dependent on any drug other than marijuana or nicotine
- Cognitively impaired
- Pregnant or breastfeeding
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Marijuana craving
Time Frame: Measured throughout the cue exposure session
|
Measured throughout the cue exposure session
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
General Publications
- Lundahl LH, Greenwald MK. Magnitude and duration of cue-induced craving for marijuana in volunteers with cannabis use disorder. Drug Alcohol Depend. 2016 Sep 1;166:143-9. doi: 10.1016/j.drugalcdep.2016.07.004. Epub 2016 Jul 18.
- Lundahl LH, Greenwald MK. Effect of oral THC pretreatment on marijuana cue-induced responses in cannabis dependent volunteers. Drug Alcohol Depend. 2015 Apr 1;149:187-93. doi: 10.1016/j.drugalcdep.2015.01.046. Epub 2015 Feb 11.
Study record dates
Study Major Dates
Study Start
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Mental Disorders
- Chemically-Induced Disorders
- Substance-Related Disorders
- Marijuana Abuse
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Analgesics, Non-Narcotic
- Hormones
- Hormones, Hormone Substitutes, and Hormone Antagonists
- Psychotropic Drugs
- Hallucinogens
- Cannabinoid Receptor Agonists
- Cannabinoid Receptor Modulators
- Dronabinol
Other Study ID Numbers
- NIDA-19236-2
- DPMCDA (Other Identifier: NIDA)
- R21DA019236 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Marijuana Abuse
-
Dartmouth-Hitchcock Medical CenterCompletedMarijuana Abuse and DependenceUnited States
-
Brown UniversityCompleted
-
New York State Psychiatric InstituteNational Institute on Drug Abuse (NIDA); Research Foundation for Mental Hygiene...CompletedMarijuana SmokingUnited States
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA)Completed
-
State University of New York at BuffaloCompleted
-
York UniversityUniversity of ManitobaCompletedMarijuana Use | Marijuana DependenceCanada
-
National Institute on Drug Abuse (NIDA)Completed
-
New York State Psychiatric InstituteNational Institute on Drug Abuse (NIDA); Research Foundation for Mental Hygiene...Completed
-
Yale UniversityNational Institute on Drug Abuse (NIDA); Hartford Hospital; Maastricht University and other collaboratorsCompletedMarijuana ImpairmentUnited States
Clinical Trials on Tetrahydrocannabinol
-
MorphotekTerminatedEpithelial Ovarian CancerUnited States, Germany
-
University of California, San DiegoRecruitingHIV | Cannabis | Microbiome | THC | Neuroinflammatory Response | Neuroinflammatory DiseaseUnited States
-
UMC UtrechtLeiden University Medical Center; Center for Human Drug Research; TI PharmaCompletedMagnetic Resonance Imaging | Memory | Reward | Tetrahydrocannabinol | EndocannabinoidsNetherlands
-
Wageningen UniversityCompletedSensory ScienceNetherlands
-
Zeria PharmaceuticalCompleted
-
City of Hope Medical CenterNational Cancer Institute (NCI)Not yet recruitingBreast Carcinoma | Chemotherapy-Induced Peripheral Neuropathy | Colon CarcinomaUnited States
-
Centre for Addiction and Mental HealthCanadian Institutes of Health Research (CIHR); Health CanadaCompleted
-
University Hospital, Gentofte, CopenhagenUniversity of CopenhagenUnknownLiver TransplantationDenmark
-
Radboud University Medical CenterEuropean UnionCompletedChronic Pain | Abdominal Pain | Pancreatitis, ChronicNetherlands
-
Ludwig-Maximilians - University of MunichGerman Federal Ministry of Education and Research; German Research Network...UnknownComplex Regional Pain Syndromes | CRPSGermany